Ignite Creation Date:
2025-12-25 @ 4:35 AM
Ignite Modification Date:
2026-01-22 @ 12:09 AM
Study NCT ID:
NCT00084318
Status:
COMPLETED
Last Update Posted:
2018-12-12
First Post:
2004-06-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Sponsor:
Organization: